Vice President Mike Pence told a news conference that the US will be starting human trials of 3,000 patients who tested positive for the coronavirus. The study would be held at at Henry Ford Hospital in Detroit and will “look at whether the drug prevents front-line workers from contracting the virus,
The announcement follows several reports from different countries about successful recoveries of patients who had tested positive for COVID-19, the disease caused by the coronavirus.
President Trump has severally mentioned the drug, and has gotten a beating on it from the media who insisted it was an unproven drug and that such pronouncements by the president were putting people at risk.
Several doctors have shared videos on social media on their successes in managing COVID-19 patients using the drug.
The trial will be “the first major, definitive study in healthcare workers and first responders of hydroxychloroquine as a preventative medication,” noted study organizer William O’Neill, an interventional cardiologist and researcher with Henry Ford Health System, in a statement.
Hydroxychloroquine has shown some promise against the coronavirus in a small French study, but it’s not federally approved to treat COVID-19, as no official studies had been conducted to determine whether it’s both safe and effective for those sick patients.